CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ofloxacin
Accession: CHEBI:7731
browse the term
Definition: A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Synonyms: exact_synonym: rac-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
related_synonym: (3RS)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; DL 8280; Exocin; Floxin; Formula=C18H20FN3O4; Gailuoxian; HOE-280; OFLX; ORF 18489; Ocuflox; Oxaldin; Prifloxcin; Prifloxin; Tarivid; Visiren; ofloxacine; ofloxacino; ofloxacinum; rac-8-fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid; rac-ofloxacin; racemic ofloxacin
alt_id: CHEBI:100146
xref: CAS:82419-36-1; DrugBank:DB01165; Drug_Central:1981; HMDB:HMDB0015296; KEGG:C07321; KEGG:D00453; LINCS:LSM-4370
xref_mesh: MESH:D015242
xref: MetaCyc:CPD-12843; PMID:11710934; PMID:11903499; PMID:12827054; PMID:15008519; PMID:15557076; PMID:16669862; PMID:1804789; PMID:19646516; PMID:24497308; PMID:24550337; PMID:3469159; PMID:3546152; PMID:35897550; PMID:36004580; PMID:36228398; PMID:36268299; PMID:6960805; PMID:7884650; PMID:9228220; Reaxys:3657947; VSDB:1898; Wikipedia:Ofloxacin
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity multiple interactions
ISO
Ofloxacin results in decreased activity of ABCB11 protein Ofloxacin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Arhgap45
Rho GTPase activating protein 45
affects expression
ISO
Ofloxacin affects the expression of ARHGAP45 mRNA
CTD
PMID:25811541
NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Ofloxacin results in increased expression of ASAH1 mRNA
CTD
PMID:17175557
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP3A4 protein results in increased metabolism of Theophylline]
CTD
PMID:11408986
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Depp1
DEPP autophagy regulator 1
increases expression
ISO
Ofloxacin results in increased expression of DEPP1 mRNA
CTD
PMID:17175557
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Il1b
interleukin 1 beta
multiple interactions
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]
CTD
PMID:16148020
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Ins1
insulin 1
increases expression
EXP
Ofloxacin results in increased expression of INS1 protein
CTD
PMID:17026994
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
Ofloxacin results in decreased expression of ITGB4 protein
CTD
PMID:14687228
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
affects binding
ISO
Ofloxacin binds to KCNH2 protein
CTD
PMID:34058295
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
G
Mmp13
matrix metallopeptidase 13
multiple interactions decreases expression
ISO
Ofloxacin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA] Ofloxacin results in decreased expression of MMP13 mRNA
CTD
PMID:16148020
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp3
matrix metallopeptidase 3
increases expression
EXP
Ofloxacin results in increased expression of MMP3 mRNA
CTD
PMID:20688128
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Nupr1
nuclear protein 1, transcriptional regulator
increases expression
ISO
Ofloxacin results in increased expression of NUPR1 mRNA
CTD
PMID:17175557
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Ofloxacin results in decreased activity of PGD protein
CTD
PMID:15558954
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Phyh
phytanoyl-CoA 2-hydroxylase
decreases expression
ISO
Ofloxacin results in decreased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr17:73,329,461...73,346,359
Ensembl chr17:73,329,082...73,346,409
G
Plaur
plasminogen activator, urokinase receptor
increases expression
EXP
Ofloxacin results in increased expression of PLAUR mRNA
CTD
PMID:20688128
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
EXP
Ofloxacin results in increased expression of PTGS2 mRNA
CTD
PMID:20688128
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
RT1-A2
RT1 class Ia, locus A2
affects expression
ISO
Ofloxacin affects the expression of HLA-E mRNA
CTD
PMID:25811541
NCBI chr20:4,870,939...4,910,183
G
Slc22a5
solute carrier family 22 member 5
multiple interactions
ISO EXP
Ofloxacin inhibits the reaction [SLC22A5 protein results in increased uptake of Carnitine]
CTD
PMID:16928358
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc2a1
solute carrier family 2 member 1
affects localization decreases expression
ISO
Ofloxacin affects the localization of SLC2A1 mRNA Ofloxacin results in decreased expression of SLC2A1 mRNA
CTD
PMID:19022360
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
EXP
Ofloxacin results in increased expression of TNFRSF12A mRNA
CTD
PMID:20688128
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of Ofloxacin
CTD
PMID:15769885
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all